• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    ImmunoClin Corporation (IMCL)

    -OTC BB
    5.00 0.00(0.00%) Dec 17, 11:44AM EST
    Add to Portfolio
    ProfileGet Profile for:
    ImmunoClin Corporation
    9107 Wilshire Boulevard
    Suite 450
    Beverly Hills, CA 90210
    United States - Map
    Phone: 888-267-1175
    Fax: 888-270-0258
    Website: http://www.pharmainvestingnews.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:N/A

    Business Summary 

    Immunoclin Corporation provides comprehensive, clinical, and basic science research services to pharmaceutical, biotechnology, and food industries. It is involved in the research and development on products, such as MIRA, an algorithm to analyze the multi-variant data to identify people who are at risk of having heart attack; and GARD, a genetic test for multiple genetic polymorphisms associated with increased risk of the most common form of dementia. Immunoclin Corporation is also engaged in the research and development of PRIMALEUKIN, an antibacterial, anti-fungal, and antiviral agent, harnessing and amplifying the body’s own natural defense against, and recovery from, infection; DACTELLIGENCE, a technology and newly patented concept in bio-sensing to challenge detection platforms in multiple diagnostic fields; and GastroWellBeing, an immunological food supplement. The company was formerly known as Pharma Investing News, Inc. and changed its name to Immunoclin Corporation in December 2013. Immunoclin Corporation is headquartered in Beverly Hills, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on ImmunoClin Corporation

    Key Executives 
     PayExercised
    Dr. Dorothy Helen Bray Ph.D., 58
    Chief Exec. Officer, Pres and Director
    21.00K0.00
    Mr. James Scott Munro , 45
    Chief Financial Officer, Principal Accounting Officer and Treasurer
    20.00K0.00
    Dr. Khadija Benlhassan , 39
    Chief Scientific Officer and Director
    1,000.000.00
    Mr. Raymond C. Dabney , 49
    Management Consultant
    21.00K0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders